VI
EVH icon

Versor Investments’s Evolent Health EVH Stock Holding History

Versor Investments’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-47,700
Closed -$912K – 828
2024
Q2 		$912K Buy
+47,700
New +$1.22M 0.17% 170

Other funds holding EVH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Versor Investments's EVH Position: Q3 2024 in Review

Versor Investments sold out of Evolent Health (EVH) in Q3 2024, closing a stake of 47,700 shares — an estimated $912K sold.

Versor Investments first reported a position in EVH in Q2 2024 and held it in 1 quarter. The position peaked at $912K in Q2 2024. 262 funds tracked by Wall St. Rank hold EVH as of Q3 2024.

  • Versor Investments reported no remaining Evolent Health position as of Q3 2024 after selling out during the quarter.
  • Versor Investments sold 47,700 Evolent Health shares in Q3 2024, an estimated $912K.
  • Versor Investments first reported a position in Evolent Health in Q2 2024 and held it in 1 quarter.
  • Versor Investments's Evolent Health position peaked at $912K in Q2 2024.
  • 262 funds tracked by Wall St. Rank held Evolent Health as of Q3 2024.

Based on Versor Investments's 13F filing for Q3 2024, filed 4 Nov 2024.